Table 2.
Case | Targeted lesion of irradiation | Fractionated exposure, n | Total dose of CIRT (GyE) | Delivered dose for heart (GyE) | Stellate ganglion (C6/C7) irradiation | Prognosis [M, months after irradiation] | ||||
---|---|---|---|---|---|---|---|---|---|---|
PA, PV, Ao | RA | LA | RV | LV | ||||||
1 | Bilateral hilar lymph node (R ≥ L) | 16 | 52.8 | 6.5 | 5.8 | 12.2 | 0 | 0 | – | Alive [78 M] |
2 | Left lung (S8) + left hilar lymph node | 1 | 44 | 19.1 | 0 | 0.7 | 0.02 | 4.3 | – | Cancer death [30 M] |
3 | Right lung (S6) + superior mediastinal lymph node | 16 | 72 | 9.1 | 4.4 | 11.8 | 0 | 0 | + (R ≥ L) | Alive [79 M] |
4 | Superior mediastinal lymph node (R < L) | 12 | 48 | 2.9 | 0 | 3.1 | 0 | 0 | + (R < L) | Cancer death [51 M] |
5 | Superior mediastinal lymph node (R > L) | 12 | 48 | 7.0 | 3.8 | 13.4 | 0 | 0 | + (R >> L) | Cancer death [63 M] |
6 | Superior mediastinal lymph node (R = L) | 12 | 48 | 1.3 | 0 | 0 | 0 | 0 | + (R = L) | Cancer death [6 M] |
7 | Superior mediastinal lymph node (R > L) | 12 | 48 | 12.3 | 13.4 | 14.5 | 0 | 0.1 | + (R > L) | Cancer death [5 M] |
8 | Superior mediastinal lymph node (R > L) | 12 | 48 | 12.1 | 22.6 | 23.1 | 0.9 | 0.1 | + (R > L) | Cancer death [14 M] |
GyE, gray equivalent; S8, anterior basal segment; S6, superior segment of the lower lobe; PA, pulmonary artery; PV, pulmonary vein; Ao, aorta; RA, right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle; C6/C7, cervical spine 6 and 7, R, right; L, left.